In vivo anticancer activity of a rhodium metalloinsertor in the HCT116 xenograft tumor model is a research paper published in Proceedings of the National Academy of Sciences (2020). On theSindex it has a DataRank of 0. It has been cited 26 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
HHS | National Institutes of Health
Grant: GM33309
HHS | NIH | National Cancer Institute
Grant: P30CA033572
NIGMS NIH HHS
Grant: R01 GM033309
NIGMS NIH HHS
Grant: R37 GM033309
National Institutes of Health
Grant: 5R01GM033309-13
METAL PROBES AND DRUG BINDING TO DNA
National Institutes of Health
Grant: 5P30CA033572-27
Developmental Funds
FWCI
1.22
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals